| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tenax Therapeutics, Inc. (TENX) has 8 insiders with recent SEC Form 4 filings, including 21 buys and 1 sell. TENX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 450.0K | $5.24M | - | |
| Other | 250.0K | $2.91M | - | |
| Dir | 30.0K | $349.5K | - | |
| Dir | 30.0K | $349.5K | - | |
| Dir | 30.0K | $349.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2020 | Armistice Capital, LLC56 | 10% Owner | Buy | 34,903 | $1.51 | $52,700.07 | +0.3% | |
| Aug 21, 2020 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 311,481 | $1.48 | $460,442.79 | +3.1% | |
| May 18, 2020 | Blanck Ronald R | Director | Buy | 5,000 | $0.95 | $4,774.00 | +470.8% | |
| Dec 18, 2017 | Blanck Ronald R | Director | Buy | 12,950 | $0.45 | $5,887.07 | +62.3% | |
| Nov 14, 2017 | Blanck Ronald R | Director | Sell | 12,950 | $0.39 | $5,050.50 | -64.4% | |
| Nov 23, 2016 | Proehl Gerald T | Director | Buy | 29,882 | $1.67 | $49,968.71 | +193.6% | |
| Feb 3, 2016 | Mitchum James P. | Director | Buy | 19,000 | $2.66 | $50,503.00 | +372.5% | |
| Nov 19, 2015 | Blanck Ronald R | Director | Buy | 1,900 | $3.20 | $6,080.00 | +14.7% | |
| Jan 20, 2015 | Blanck Ronald R | Director | Buy | 2,000 | $3.49 | $6,980.00 | +24.4% |